/w=256,quality=90,fit=scale-down){kind=logo}
About TruBit
About MMXNMore Languages
🇲🇽 Español
🇧🇷 Português
⭐️ 中文
What is Injective (INJ)?
Injective (INJ) - The native cryptocurrency of the Injective platform, based on the Cosmos blockchain
Sitio Web Explorador Documentación
- The decentralized platform Injective Protocol has its own cryptocurrency called Injective (INJ).
- It is based on the Cosmos blockchain, so it improves on its scalability and transaction speed.
- Users can use INJ to pay transaction fees, vote on governance decisions and get discounts on transaction fees.
Key Metrics Injective (INJ)
| Precio Reciente | $4.35 |
|---|---|
Cap de Mercado | $317,152,809 |
Suministro Circulante | 73,005,554 INJ |
Suministro Total | 100,000,000 |
Suministro Máximo | 100,000,000 |
/w=3840,quality=90,fit=scale-down)
What is Injective (INJ)?
Injective (INJ) is a cryptocurrency that is used on the decentralized Injective Protocol platform. The Injective (INJ) platform is a decentralized cryptocurrency exchange that uses smart contract technology to allow users to exchange a wide variety of assets without the need for a centralized intermediary.
Injective (INJ) was founded in 2018 by Eric Chen, Albert Chon, and Mirza Uddin, with the goal of creating a decentralized cryptocurrency exchange that could offer users a faster and more scalable trading experience. The founding team had previous experience in technology and cryptocurrency companies, which allowed them to develop an ambitious project.
The Injective (INJ) platform was launched in 2020, following a successful launch of its test network in 2019. Since then, the platform has been growing and attracting the attention of cryptocurrency investors and users around the world.
In December 2020, Injective (INJ) raised $10 million in a funding round led by Pantera Capital and other well-known investors in the cryptocurrency space. The investment helped the platform expand and improve its technology.
In 2021, Injective (INJ) partnered with major cryptocurrency projects such as Chainlink and Binance, which helped increase the platform's visibility. In addition, the Injective (INJ) development team has been working hard to launch new features and products, such as the decentralized futures platform, which was launched in July 2021.
The Injective (INJ) platform is based on Cosmos blockchain technology, which allows for greater scalability and transaction speed compared to other smart contract platforms. The platform allows users to exchange assets from different blockchains, such as Ethereum, Bitcoin, Binance Smart Chain and more.
Injective (INJ): what makes it different and why invest?
The INJ cryptocurrency is used as a utility token on the Injective Protocol platform.
INJ can be bought and sold on various cryptocurrency exchanges, such as TruBit. As with all cryptocurrencies, it is important to do your own research and understand the risks before investing in INJ or any other cryptocurrency.
Injective (INJ) allows investors to participate in organizational projects in decentralized finance (DeFi). In addition, this blockchain gives everyone the possibility to do business, regardless of the amount of money you want to invest.
The total supply of Injective (INJ) tokens is 100,000,000, of which there are about 15,406,012 in circulation at the beginning of 2023. According to their official document, there is a 7% inflation set for the price to remain stable for the first few years of the project, but inflation will be gradually reduced to 2%.
